Risk Factors for Recent HIV Infections among Adults in 14 Countries in Africa Identified by Population-Based HIV Impact Assessment Surveys, 2015-2019.

Cameroon Côte d’Ivoire Eswatini Ethiopia HIV HIV/AIDS and other retroviruses Kenya Lesotho Malawi Namibia Nigeria PHIA Population-Based HIV Impact Assessment Rwanda Tanzania Uganda Zambia Zimbabwe cross-sectional studies sexually transmitted diseases sexually transmitted infections viruses zoonoses

Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
11 2023
Historique:
medline: 26 10 2023
pubmed: 25 10 2023
entrez: 25 10 2023
Statut: ppublish

Résumé

Identifying persons who have newly acquired HIV infections is critical for characterizing the HIV epidemic direction. We analyzed pooled data from nationally representative Population-Based HIV Impact Assessment surveys conducted across 14 countries in Africa for recent infection risk factors. We included adults 15-49 years of age who had sex during the previous year and used a recent infection testing algorithm to distinguish recent from long-term infections. We collected risk factor information via participant interviews and assessed correlates of recent infection using multinomial logistic regression, incorporating each survey's complex sampling design. Compared with HIV-negative persons, persons with higher odds of recent HIV infection were women, were divorced/separated/widowed, had multiple recent sex partners, had a recent HIV-positive sex partner or one with unknown status, and lived in communities with higher HIV viremia prevalence. Prevention programs focusing on persons at higher risk for HIV and their sexual partners will contribute to reducing HIV incidence.

Identifiants

pubmed: 37877591
doi: 10.3201/eid2911.230703
pmc: PMC10617335
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

2325-2334

Subventions

Organisme : CGH CDC HHS
ID : U2G GH001226
Pays : United States
Organisme : PEPFAR
Pays : United States

Références

J Acquir Immune Defic Syndr. 2011 Apr 15;56(5):453-9
pubmed: 21297483
N Engl J Med. 2018 May 17;378(20):1859-1861
pubmed: 29768142
Transbound Emerg Dis. 2020 Nov;67(6):2372-2388
pubmed: 32396689
Lancet HIV. 2017 Oct;4(10):e457-e464
pubmed: 28801191
J Acquir Immune Defic Syndr. 2021 Aug 1;87(Suppl 1):S89-S96
pubmed: 33765683
J Acquir Immune Defic Syndr. 2021 Aug 1;87(Suppl 1):S17-S27
pubmed: 34166309
MMWR Morb Mortal Wkly Rep. 2022 Mar 04;71(9):329-334
pubmed: 35239633
J Acquir Immune Defic Syndr. 2021 Aug 1;87(Suppl 1):S6-S16
pubmed: 34166308
Curr HIV/AIDS Rep. 2020 Jun;17(3):249-258
pubmed: 32297219
J Int AIDS Soc. 2021 Oct;24(10):e25818
pubmed: 34672104
J Acquir Immune Defic Syndr. 2023 Mar 1;92(3):189-196
pubmed: 36730779
AIDS Res Ther. 2013 Dec 13;10(1):30
pubmed: 24330537
J Int AIDS Soc. 2022 Jan;25(1):e25861
pubmed: 35001515
BMC Infect Dis. 2020 Mar 6;20(1):198
pubmed: 32138696
PLoS One. 2012;7(3):e33328
pubmed: 22479384
J Infect Dis. 2023 Apr 01;:
pubmed: 37002831
J Acquir Immune Defic Syndr. 2021 Aug 1;87(Suppl 1):S73-S80
pubmed: 34166315
JAMA. 2008 Aug 6;300(5):540-9
pubmed: 18677026
Cochrane Database Syst Rev. 2009 Apr 15;(2):CD003362
pubmed: 19370585
Lancet HIV. 2019 Dec;6(12):e831-e859
pubmed: 31439534
HIV AIDS (Auckl). 2019 May 16;11:105-117
pubmed: 31191036
PLoS One. 2016 May 19;11(5):e0155498
pubmed: 27195800
N Engl J Med. 2011 Aug 11;365(6):493-505
pubmed: 21767103
Nat Commun. 2019 Dec 2;10(1):5482
pubmed: 31792217
Lancet HIV. 2021 Jul;8(7):e429-e439
pubmed: 34197773
PLoS Med. 2018 Oct 25;15(10):e1002678
pubmed: 30359372
JAMA. 2016 Jul 12;316(2):171-81
pubmed: 27404185
Lancet HIV. 2018 Apr;5(4):e181-e189
pubmed: 29490875
AIDS. 2019 Jul 15;33(9):1527-1529
pubmed: 31021850

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH